share_log

UBS Maintains Neutral on Calumet Specialty Prods, Raises Price Target to $19.5

UBS Maintains Neutral on Calumet Specialty Prods, Raises Price Target to $19.5

瑞银对Calumet专业产品保持中立,将目标股价上调至19.5美元
Benzinga ·  2023/05/15 07:36

UBS analyst Manav Gupta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Neutral and raises the price target from $18.5 to $19.5.

瑞银分析师马纳夫·古普塔将Calumet Specialty Prods(纳斯达克股票代码:CLMT)维持在中性,并将目标股价从18.5美元上调至19.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发